Preformulation studies of a novel HIV protease inhibitor, AG1343.
about
Nelfinavir mesylate: a protease inhibitor.Role of P-glycoprotein in distribution of nelfinavir across the blood-mammary tissue barrier and blood-brain barrier.HIV-1 protease inhibitors in development.Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.New HIV protease inhibitors for drug-resistant viruses
P2860
Preformulation studies of a novel HIV protease inhibitor, AG1343.
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@ast
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@en
type
label
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@ast
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@en
prefLabel
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@ast
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@en
P2093
P356
P1476
Preformulation studies of a novel HIV protease inhibitor, AG1343.
@en
P2093
P304
P356
10.1002/JPS.2600840911
P407
P577
1995-09-01T00:00:00Z